Clinical trials
Recruiting Phase 1/2 Liver Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essen Biotech | 2 |
| Eureka Therapeutics Inc. | 2 |
| 7 Hills Pharma, LLC | 1 |
| AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | 1 |
| Beijing Biotech | 1 |
| DualityBio Inc. | 1 |
| ModeX Therapeutics, An OPKO Health Company | 1 |
| Pfizer | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
| Second Life Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 13 |
| Breast Neoplasms | 6 |
| Carcinoma, Hepatocellular | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Ovarian Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Kidney Neoplasms | 4 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.